General Information
Revision date
2020-09-25
Product name
Human Chorionic Gonadotropin Formulation
CAS No.
9002-61-3
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360Fd, H372
Hazard statements
Code
Statements
H360Fd
May damage fertility; Suspected of damaging the unborn child
Section 2
CLP CLASSIFICATION
Reproductive toxicity, Category 1A H360Fd: May damage fertility. Suspected of dam- aging the unborn child. Specific target organ toxicity - repeated H372: Causes damage to organs through pro- exposure, Category 1 longed or repeated exposure.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H360Fd May damage fertility. Suspected of damaging the unborn child. H372 Causes damage to organs through prolonged or re- peated exposure.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Hazardous Ingredients
Gonadotropin, chorionic
2.3 Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.
